World Pharma News Digest - 11.03.2014
11 views
Skip to first unread message
Ruslan David
Mar 11, 2014, 8:16:45 AM3/11/14
to worldph...@googlegroups.com
GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
GlaxoSmithKline plc (LSE:GSK) announced that, following the voluntary Open Offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, GSK has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited), from 50.7% to 75%. GlaxoSmithKline Pharmaceuticals Limited will remain publicly-listed.
Read more...
http://www.worldpharmanews.com/gsk/2722-gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-
Investigational drug may increase survival for some patients with advanced melanoma
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.
Read more...
http://www.worldpharmanews.com/research/2721-investigational-drug-may-increase-survival-for-some-patients-with-advanced-melanoma
Pradaxa® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation
More than 100 countries have now approved Boehringer Ingelheim's Pradaxa® for the prevention of stroke and systemic embolism for adult patients with the most common sustained heart rhythm condition (non-valvular atrial fibrillation, nvAF).(1) The 100th approval was announced by the Jordan Food and Drug Administration. Further regulatory approvals for Pradaxa® are expected to be received in the near future.
Read more...
http://www.worldpharmanews.com/boehringer-ingelheim/2720-pradaxar-dabigatran-etexilate-now-approved-in-more-than-100-countries-for-stroke-prevention-in-atrial-fibrillation
Gene therapy locks out HIV, paving the way to control virus without antiretroviral drug
University of Pennsylvania researchers have successfully genetically engineered the immune cells of 12 HIV positive patients to resist infection, and decreased the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely - including one patient whose levels became undetectable. The study, appearing in the New England Journal of Medicine, is the first published report of any gene editing approach in humans.
Read more...
http://www.worldpharmanews.com/research/2719-gene-therapy-locks-out-hiv-paving-the-way-to-control-virus-without-antiretroviral-drug
Female fertility: What's testosterone got to do with it?
Several fertility clinics across the country are beginning to administer testosterone, either through a patch or a gel on the skin, to increase the number of eggs produced by certain women undergoing in vitro fertilization (IVF). Women are also purchasing the over-the-counter supplement DHEA, which is converted by the body into testosterone, to boost their chances of pregnancy with IVF.
Read more...
http://www.worldpharmanews.com/research/2718-female-fertility-whats-testosterone-got-to-do-with-it
PharmaNews.eu / Latest News
Plant extract hope for infant muscle disease
http://www.pharmanews.eu/research-and-development/1411-plant-extract-hope-for-infant-muscle-disease
Detecting levels of antibiotics in blood paves the way to individualized treatment
http://www.pharmanews.eu/research-and-development/1410-detecting-levels-of-antibiotics-in-blood-paves-the-way-to-individualized-treatment
Researchers discover new strategies for the treatment of psoriasis
http://www.pharmanews.eu/research-and-development/1409-researchers-discover-new-strategies-for-the-treatment-of-psoriasis
Strawberries lower cholesterol
http://www.pharmanews.eu/research-and-development/1408-strawberries-lower-cholesterol
Scientists unlock a 'microbial Pompeii'
http://www.pharmanews.eu/research-and-development/1407-scientists-unlock-a-microbial-pompeii
eHealth Forum 2014
http://www.pharmanews.eu/conferences-and-events/1406-ehealth-forum-2014
Kidney cancer reveals its weak link
http://www.pharmanews.eu/research-and-development/1405-kidney-cancer-reveals-its-weak-link
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
GlaxoSmithKline plc (LSE:GSK) announced that, following the voluntary Open Offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, GSK has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India (GlaxoSmithKline Pharmaceuticals Limited), from 50.7% to 75%. GlaxoSmithKline Pharmaceuticals Limited will remain publicly-listed.
Read more...
http://www.worldpharmanews.com/gsk/2722-gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-
Investigational drug may increase survival for some patients with advanced melanoma
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. All patients had experienced disease progression despite prior systemic therapies, and most had received two or more prior treatments.
Read more...
http://www.worldpharmanews.com/research/2721-investigational-drug-may-increase-survival-for-some-patients-with-advanced-melanoma
Pradaxa® (dabigatran etexilate) now approved in more than 100 countries for stroke prevention in atrial fibrillation
More than 100 countries have now approved Boehringer Ingelheim's Pradaxa® for the prevention of stroke and systemic embolism for adult patients with the most common sustained heart rhythm condition (non-valvular atrial fibrillation, nvAF).(1) The 100th approval was announced by the Jordan Food and Drug Administration. Further regulatory approvals for Pradaxa® are expected to be received in the near future.
Read more...
http://www.worldpharmanews.com/boehringer-ingelheim/2720-pradaxar-dabigatran-etexilate-now-approved-in-more-than-100-countries-for-stroke-prevention-in-atrial-fibrillation
Gene therapy locks out HIV, paving the way to control virus without antiretroviral drug
University of Pennsylvania researchers have successfully genetically engineered the immune cells of 12 HIV positive patients to resist infection, and decreased the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely - including one patient whose levels became undetectable. The study, appearing in the New England Journal of Medicine, is the first published report of any gene editing approach in humans.
Read more...
http://www.worldpharmanews.com/research/2719-gene-therapy-locks-out-hiv-paving-the-way-to-control-virus-without-antiretroviral-drug
Female fertility: What's testosterone got to do with it?
Several fertility clinics across the country are beginning to administer testosterone, either through a patch or a gel on the skin, to increase the number of eggs produced by certain women undergoing in vitro fertilization (IVF). Women are also purchasing the over-the-counter supplement DHEA, which is converted by the body into testosterone, to boost their chances of pregnancy with IVF.
Read more...
http://www.worldpharmanews.com/research/2718-female-fertility-whats-testosterone-got-to-do-with-it
PharmaNews.eu / Latest News
Plant extract hope for infant muscle disease
http://www.pharmanews.eu/research-and-development/1411-plant-extract-hope-for-infant-muscle-disease
Detecting levels of antibiotics in blood paves the way to individualized treatment
http://www.pharmanews.eu/research-and-development/1410-detecting-levels-of-antibiotics-in-blood-paves-the-way-to-individualized-treatment
Researchers discover new strategies for the treatment of psoriasis
http://www.pharmanews.eu/research-and-development/1409-researchers-discover-new-strategies-for-the-treatment-of-psoriasis
Strawberries lower cholesterol
http://www.pharmanews.eu/research-and-development/1408-strawberries-lower-cholesterol
Scientists unlock a 'microbial Pompeii'
http://www.pharmanews.eu/research-and-development/1407-scientists-unlock-a-microbial-pompeii
eHealth Forum 2014
http://www.pharmanews.eu/conferences-and-events/1406-ehealth-forum-2014
Kidney cancer reveals its weak link
http://www.pharmanews.eu/research-and-development/1405-kidney-cancer-reveals-its-weak-link
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages